Sutro Biopharma, Inc. · NASDAQ:STRO
Perceptive Advisors LLC reported a 5.40% stake in Sutro Biopharma, Inc. (Schedule 13G)
Event Apr 14, 2026 · Filed Apr 21, 2026
Perceptive Advisors LLC reported a 5.40% stake in Sutro Biopharma, Inc., 898,025 shares, as a passive investor on Apr 14, 2026. Filed Apr 21, 2026 (Schedule 13G).
- Stake
- 5.40%
- Shares
- 898,025
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Perceptive Advisors LLC | 5.40% | 898,025 |
| Joseph Edelman | 5.40% | 898,025 |
| Perceptive Life Sciences Master Fund, Ltd. | 5.40% | 898,025 |
Source
Related
- Sutro Biopharma, Inc.
- Perceptive Advisors LLC
- Sutro Biopharma, Inc. shareholders
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026
- Form 4 · Gerber Hans-Peter · Sep 22, 2026
- Schedule 13G/A · Point72 Asset Management, L.P. · Aug 14, 2026
- Schedule 13G · BlackRock, Inc. · Jul 30, 2026
- Form 4 · Chow Gregory K. · Jun 2, 2026
- Schedule 13G · Srinivas Akkaraju · May 15, 2026